Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study

C. Yen,Rohini Sharma,Lorenza Rimassa,Tadaaki Arizumi,D Bettinger,Joanne Evans,T. Pressiani,M.E. Burlone,Mario Pirisi,Laura Giordano,Jessica Howell,Masatoshi Kudo,Robert Thimme,Joong Won Park,David J. Pinato

Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study

2017

C. Yen
Rohini Sharma
Lorenza Rimassa
Tadaaki Arizumi
D Bettinger
Joanne Evans
T. Pressiani
M.E. Burlone
Mario Pirisi
Laura Giordano
Jessica Howell
Masatoshi Kudo
Robert Thimme
Joong Won Park
David J. Pinato

Background: Level I evidence supports the use of sorafenib in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma, where heterogen

Keywords:

Hepatocellular carcinoma
Observational study
General surgery
Liver cancer
Sorafenib
Medicine
Internal medicine
Oncology
in patient
Diabetes mellitus
stage migration

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations